Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 1 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Bracco Suisse SA has 3 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 3 examiners but 1 art unit, indicating that the technical setting is shared while examination responsibility is divided.
DICKINSON, PAUL W is the busiest examiner, with 1 pending matter. Counsel can coordinate substantive positions across the files while responding to the distinct records maintained by each examiner.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| Double-patenting + other | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DICKINSON, PAUL W | 1 | 63.2% | +9.6% |
| CRAIG, KAILA ANGELIQUE | 1 | 33.8% | +25.2% |
| BAEK, JONGHWAN NMN | 1 | 50.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18722126 | MICROFLUIDIC PREPARATION OF NANODROPLETS WITH FLUORINATED COMPOUND | DICKINSON, PAUL W | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18719175 | METHOD FOR EXTRACTING A FLUORINATED GAS | CRAIG, KAILA ANGELIQUE | 12d |
| Art Unit | Apps |
|---|---|
| 1618 | 3 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18722126 | MICROFLUIDIC PREPARATION OF NANODROPLETS WITH FLUORINATED COMPOUND | DICKINSON, PAUL W | 1618 | §102§103§112 | Non-Final OA | — | Pending | Jun 20, 2024 |
| 18719175 | METHOD FOR EXTRACTING A FLUORINATED GAS | CRAIG, KAILA ANGELIQUE | 1618 | §103 | Non-Final OA | 12d | Pending | Jun 12, 2024 |
| 18708660 | MICROFLUIDIC PREPARATION OF FLUOROCARBON CROSS-LINKED VESICLES | BAEK, JONGHWAN NMN | 1618 | §103DP | Non-Final OA | — | Pending | May 09, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBracco Suisse SA has 3 pending office actions as of October 2026, spread across 1 art units and 3 examiners.
Paul W Dickinson has the most, with 1 of Bracco Suisse SA's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
